Skip to main content

Global Oncology Informatics Market – Benefits to Caregivers, Payers, and Researchers

 An increasing demand from clinicians for the electronic collection of cancer-related data has led to the electronic collection of data that can efficiently facilitate personalized care for patients and catalyze real-time clinical research studies.

The importance of EHR (for electronic collection of data) has been recognized by organizations, such as the American Society of Clinical Oncology (ASCO). In 2010, ASCO released the final draft of the Certification Commission for Health Information Technology (CCHIT) criteria for the oncology EHR certification for the EHR vendors.

Under oncology informatics, the products are highlighted to cover the complete treatment process. Information is collated from different medical specialties, such as surgery, chemotherapy, pathology, and radiotherapy. There are various forms of specialist oncology information systems aimed at identifying common processing across tumor streams.

Following are the several information systems included in oncology informatics. These systems are majorly used for patient management and data recording purposes.

·         Oncology EMR: These systems are often compatible with a wide range of image types such as CT scans, PET scans, mammograms, ultrasounds, MRIs, and other scans.

·         Oncology information systems (OIS): These systems are offered by specialist suppliers in the market and are often associated with other types of oncology technology, such as linear accelerators (LINACs).

·         Oncology clinical care information systems (OCCIS): These systems offer enhanced control over all aspects of interface design, data flow, and workflow.

According to the market intelligence published by BIS Research, the global oncology informatics market is expected to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025. With increasing incidences of cancer, the burden on clinicians to effectively manage oncology-related data to ensure enhanced patient outcomes.

. Furthermore, in recent years, organizations such as Centers for Medicare and Medicaid Services (CMS) have reduced reimbursement rates and procedure time in a clinical setting. 

This further necessitates the selection of an integrated health record system. For instance, in 2013, CMS implemented changes in payment policies, which resulted in an overall 15% reduction in rates of radiation oncology services. These changes comprised a 7% change in treatment times for intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) procedure codes.

Further, oncology informatics has several benefits for care providers, payers, and researchers. For instance, it offers in detail aggregation of patient-related information, such as plan of treatment, its status, and patient's response to it. For caregivers, it offers storage of drug toxicity and clinical trial information at one centralized location, and for payers, it offers assistance in designing reimbursement strategies. Lastly, for researchers, it streamlines  tasks such as data retrieval, analysis, and prediction of probable outcomes.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...